When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARQT - Arcutis's roflumilast cream shows positive outcome in mid-stage psoriasis study
Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics (ARQT-0.5%) has announced preliminary results for the first cohort of its ongoing Phase 2 long-term safety study evaluating topical roflumilast cream 0.3% (ARQ-151), for plaque psoriasis.
More news on: Arcutis Biotherapeutics, Inc., Healthcare stocks news,